Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 596 | 320 | 1,373 | 701 | 380 |
| Income taxes - deferred | 3 | -1 | -157 | 91 | 15 |
| Other Working Capital | -107 | -68 | 89 | 58 | 29 |
| Operating Cash Flow | $492 | $251 | $1,305 | $850 | $424 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -1,275 | -1,275 | -1,275 | -1,275 | -1,275 |
| Financing Cash Flow | $-1,275 | $-1,275 | $-1,275 | $-1,275 | $-1,275 |
| Beginning Cash Position | 47,012 | 47,012 | 46,982 | 46,982 | 46,982 |
| End Cash Position | 46,229 | 45,988 | 47,012 | 46,557 | 46,131 |
| Net Cash Flow | $-783 | $-1,024 | $30 | $-425 | $-851 |
| Free Cash Flow | |||||
| Operating Cash Flow | 492 | 251 | 1,305 | 850 | 424 |
| Free Cash Flow | 492 | 251 | 1,305 | 850 | 424 |